Stay updated on KN026 in Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the KN026 in Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KN026 in Metastatic Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3; the previous revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T14:54:58.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed Revision: v3.4.1; and replaced a government funding status notice. These changes affect page presentation and status messaging but do not alter trial data, eligibility, or outcomes shown on the page.
    Difference
    0.5%
    Check dated 2026-02-11T02:04:09.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A government funding status notice and an NIH operating status banner were added, and the site revision note was updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-03T23:16:40.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Introduced Show glossary option and Revision: v3.4.0. Updated the QC-related label to 'Last Update Submitted that Met QC Criteria' and standardized capitalization for No FEAR Act data.
    Difference
    0.2%
    Check dated 2026-01-27T21:54:13.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The last known status line now indicates Jiangsu Alphamab Biopharmaceuticals Co., Ltd as of September 2023, with status marked as Verified and Unknown.
    Difference
    0.4%
    Check dated 2026-01-06T16:36:30.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added Heilongjiang as a Location (Harbin, Heilongjiang, China) and removed the prior Heilongjiang Locations entry; page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:43:51.000Z thumbnail image

Stay in the know with updates to KN026 in Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KN026 in Metastatic Breast Cancer Clinical Trial page.